In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis
- PMID: 2967306
- DOI: 10.1007/BF00917899
In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis
Abstract
We investigated the relationship of soluble interleukin 2 receptor (sIL2R) production to cellular IL2R expression and DNA synthesis by mitogen-stimulated mononuclear cells from blood donors seropositive for human immunodeficiency virus (HIV). SIL2R was measured using an enzyme-linked immunosorbent assay which employed 2 anti-IL2R monoclonal antibodies recognizing distinct IL2R epitopes. Decreased phytohemagglutinin-induced DNA synthesis and cellular IL2R expression were accompanied by decreased levels of sIL2R in cell culture supernatants. Similar findings were observed for pokeweed mitogen-induced responses. There was no detectable spontaneous secretion of sIL2R into culture supernatants by unstimulated mononuclear cells from either HIV-seropositive or control seronegative donors. These findings indicate that the in vitro T-cell activation defects which characterize HIV infection include decreased sIL2R production, as well as decreased cellular IL2R expression and DNA synthesis. Further, they show that assessment of supernatant sIL2R levels can be used as a valid, reliable assay for T-cell activation.
Similar articles
-
In vitro activation of T lymphocytes from HIV-seropositive blood donors. II. Decreased mitogen-induced expression of interleukin 2 receptor by both CD4 and CD8 cell subsets.Clin Immunol Immunopathol. 1988 Aug;48(2):132-9. doi: 10.1016/0090-1229(88)90077-3. Clin Immunol Immunopathol. 1988. PMID: 2968871
-
Soluble interleukin 2 receptor release, interleukin 2 production, and interleukin 2 receptor expression in activated T-lymphocytes in vitro.Pathology. 1991 Jul;23(3):224-8. doi: 10.3109/00313029109063570. Pathology. 1991. PMID: 1838146
-
Early activation marker expression to detect impaired proliferative responses to pokeweed mitogen and tetanus toxoid: studies in patients with AIDS and related disorders.Diagn Immunol. 1986;4(6):306-11. Diagn Immunol. 1986. PMID: 3102150
-
T-lymphocyte activation in IgA nephropathy: serum-soluble interleukin 2 receptor level, interleukin 2 production, and interleukin 2 receptor expression by cultured lymphocytes.J Clin Immunol. 1989 Nov;9(6):485-92. doi: 10.1007/BF00918018. J Clin Immunol. 1989. PMID: 2630571
-
Immunopathogenesis of the acquired immunodeficiency syndrome.Ann Intern Med. 1985 Nov;103(5):704-9. doi: 10.7326/0003-4819-103-5-704. Ann Intern Med. 1985. PMID: 2996403 Review.
Cited by
-
Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency.Clin Exp Immunol. 1991 Nov;86(2):252-5. doi: 10.1111/j.1365-2249.1991.tb05805.x. Clin Exp Immunol. 1991. PMID: 1934593 Free PMC article.
-
Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.Clin Exp Immunol. 1992 Jun;88(3):548-54. doi: 10.1111/j.1365-2249.1992.tb06485.x. Clin Exp Immunol. 1992. PMID: 1606739 Free PMC article.
-
Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes.Clin Diagn Lab Immunol. 1997 Jan;4(1):64-9. doi: 10.1128/cdli.4.1.64-69.1997. Clin Diagn Lab Immunol. 1997. PMID: 9008283 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical